These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 20143419
1. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease. Corona JC, Gimenez-Cassina A, Lim F, Díaz-Nido J. J Neurosci Res; 2010 Jul; 88(9):1943-50. PubMed ID: 20143419 [Abstract] [Full Text] [Related]
2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L, Garris BL, Garris DR, Lau YS. Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572 [Abstract] [Full Text] [Related]
3. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models. Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S. J Neurosci Res; 2009 Feb 19; 87(2):576-85. PubMed ID: 18803299 [Abstract] [Full Text] [Related]
4. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway. Teng X, Sakai T, Liu L, Sakai R, Kaji R, Fukui K. J Neurochem; 2006 May 19; 97(4):1126-35. PubMed ID: 16686692 [Abstract] [Full Text] [Related]
5. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. Chao YX, He BP, Tay SS. J Neuroimmunol; 2009 Nov 30; 216(1-2):39-50. PubMed ID: 19819031 [Abstract] [Full Text] [Related]
8. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito MS, Brown EM, Miller MS, Carswell S. J Pharmacol Exp Ther; 1999 Feb 30; 288(2):421-7. PubMed ID: 9918541 [Abstract] [Full Text] [Related]
9. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T. Glia; 2003 May 30; 42(3):307-13. PubMed ID: 12673835 [Abstract] [Full Text] [Related]
10. Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. Dong Z, Wolfer DP, Lipp HP, Büeler H. Mol Ther; 2005 Jan 30; 11(1):80-8. PubMed ID: 15585408 [Abstract] [Full Text] [Related]
11. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease. Nagel F, Falkenburger BH, Tönges L, Kowsky S, Pöppelmeyer C, Schulz JB, Bähr M, Dietz GP. J Neurochem; 2008 May 30; 105(3):853-64. PubMed ID: 18182047 [Abstract] [Full Text] [Related]
12. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M. J Neurosci Res; 2007 Jun 30; 85(8):1752-61. PubMed ID: 17469135 [Abstract] [Full Text] [Related]
13. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats. Rojo AI, Cavada C, de Sagarra MR, Cuadrado A. Exp Neurol; 2007 Nov 30; 208(1):120-6. PubMed ID: 17880941 [Abstract] [Full Text] [Related]
14. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease. Watanabe Y, Himeda T, Araki T. Med Sci Monit; 2005 Jan 30; 11(1):RA17-23. PubMed ID: 15614202 [Abstract] [Full Text] [Related]
15. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. Dong Z, Ferger B, Feldon J, Büeler H. J Neurobiol; 2002 Oct 30; 53(1):1-10. PubMed ID: 12360578 [Abstract] [Full Text] [Related]
16. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH. J Neurochem; 2006 May 30; 97(3):675-86. PubMed ID: 16573658 [Abstract] [Full Text] [Related]
17. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model. Tapias V, Cannon JR, Greenamyre JT. J Neurosci Res; 2010 Feb 01; 88(2):420-7. PubMed ID: 19681169 [Abstract] [Full Text] [Related]
19. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice. Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T. Neurochem Int; 2009 Dec 01; 55(8):760-7. PubMed ID: 19647776 [Abstract] [Full Text] [Related]
20. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice. Sakai R, Irie Y, Murata T, Ishige A, Anjiki N, Watanabe K. Phytother Res; 2007 Sep 01; 21(9):868-73. PubMed ID: 17486689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]